Verification of CyberKnife Dose Distributions with Gafchromic EBT2 Film
Verification of CyberKnife Dose Distributions with Gafchromic EBT2 Film
OBJECTIVECyberKnife (CK) system is more sophisticated than the conventional methods; therefore, strict qualityassurance tests are required. To ensure that the treatment is delivered as planned, the verification of thetreatment plan should be performed with specific dosimetry tools. This study aims to verify the CKtreatment plans generated for patients with intracranial tumors using Gafchromic EBT2 film.METHODSThe CK plans of ten patients with intracranial tumors were selected for this study. The plans were transferred to computed tomography images of the anthropomorphic head phantom. The phantom containing the film was irradiated using 6D skull tracking method. The dose distributions calculated by TPSwere compared with those measured by film using gamma analysis method.RESULTSIn the gamma-index method, the average passing rate for the 3%/3 mm criterion was found to be93.9±4.8%. The gamma passing rate for Iris-collimator-based plans yielded slightly lower than that forfixed-collimator-based plans.CONCLUSIONIn conclusion, this study indicates that Gafchromic EBT2 film is a utilizable dosimeter for quality assurance of the CK treatment plans. It is recommended to use the EBT2 film for verification of the CKtreatment plans before delivery to the patient.
___
- 1. Niranjan A, Bowden G, Flickinger JC, Lunsford LD. Gamma Knife Radiosurgery. In: Chin LS, Regine WF, editors. Principles and practice of stereotactic radiosurgery. 2nd ed. New York: Springer; 2015. p. 111–9.
- 2. Saw CB, Bao S, Li S. A review on the technical and dosimetric aspects of stereotactic body radiation therapy (SBRT). Journal of Radiation Oncology 2012;1(4):317–22.
- 3. Kilby W, Dooley JR, Kuduvalli G, Sayeh S, Maurer CR Jr. The CyberKnife Robotic Radiosurgery System in 2010. Technol Cancer Res Treat 2010;9(5):433–52.
- 4. Dieterich S, Cavedon C, Chuang CF, Cohen AB, Garrett JA, Lee CL, et al. Report of AAPM TG 135: quality assurance for robotic radiosurgery. Med Phys 2011;38(6):2914–36.
- 5. Reinhardt S, Würl M, Greubel C, Humble N, Wilkens JJ, Hillbrand M, et al. Investigation of EBT2 and EBT3 films for proton dosimetry in the 4-20 MeV energy range. Radiat Environ Biophys 2015;54(1):71–9.
- 6. Andrés C, del Castillo A, Tortosa R, Alonso D, Barquero R. A comprehensive study of the Gafchromic EBT2 radiochromic film. A comparison with EBT. Med Phys 2010;37(12):6271–8.
- 7. Kairn T, Hardcastle N, Kenny J, Meldrum R, Tomé WA, Aland T. EBT2 radiochromic film for quality assurance of complex IMRT treatments of the prostate: micro-collimated IMRT, RapidArc, and TomoTherapy. Australas Phys Eng Sci Med 2011;34(3):333–43.
- 8. Cheung T, Butson MJ, Yu PK. Post-irradiation colouration of Gafchromic EBT radiochromic film. Phys Med Biol 2005;50(20):N281–5.
- 9. Low DA, Dempsey JF. Evaluation of the gamma dose distribution comparison method. Med Phys 2003;30(9):2455–64.
- 10.Chan MF, Zhang Q, Li J, Parhar P, Schupak K, Burman C. The verification of iPlan commissioning by radiochromic EBT2 films. Int J Med Phys Clin Eng Radiat Oncol 2012;1(1):1–7.
- 11.Budgell GJ, Perrin BA, Mott JH, Fairfoul J, Mackay RI. Quantitative analysis of patient-specific dosimetric IMRT verification. Phys Med Biol 2005;50(1):103– 19.
- 12.Agazaryan N, Solberg TD, DeMarco JJ. Patient specific quality assurance for the delivery of intensity modulated radiotherapy. J Appl Clin Med Phys 2003;4(1):40–50.
- 13.Mardirossian G, Koltermann P, Mirzasadeghi M, Muniruzzaman M.: Implementing patient specific plan QA for CyberKnife: comparison between two independent systems. Med Phys 2010;37:3257.
- 14.Bellec J, Delaby N, Jouyaux F, Perdrieux M, Bouvier J, Sorel S, et al. Plan delivery quality assurance for CyberKnife: Statistical process control analysis of 350 film-based patient-specific QAs. Phys Med 2017;39:50–8.